biotech / news / / Reuters
The investment follows praise from drugmakers including AstraZeneca for a U.S.-UK agreement aimed at increasing medicine prices in Britain.
AstraZeneca is investing 300 million pounds in UK life sciences due to a new US-UK deal.
KEY POINTS
- The investment will complete the Rosalind Franklin building and develop a 'lab of the future' in Cambridge.
- The US-UK agreement will align UK medicine prices with US most-favored-nation pricing policies.
- The investment is expected to secure 1,000 jobs in Cambridge and Macclesfield.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →